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Abstract
Influenza A infection is a global disease that has been responsible for four pandemics over the last one hundred years.
However, it remains poorly understood as to why some infected individuals succumb to life threatening complications
whilst others recover and are relatively unaffected. Using gene-expression analysis of circulating leukocytes, here we show
that the progression towards severe influenza A infection is characterised by an abnormal transcriptional reprogramming of
cell cycle and apoptosis pathways. In severely infected humans, leukocyte gene-expression profiles display opposing cell
cycle activities; an increased aberrant DNA replication in the G1/S phase yet delayed progression in the G2/M phase. In mild
infection, cell cycle perturbations are fewer and are integrated with an efficient apoptotic program. Importantly, the loss of
integration between cell cycle perturbations and apoptosis marks the transition from a mild viral illness to a severe, life
threatening infection. Our findings suggest that circulating immune cells may play a significant role in the evolution of the
host response. Further study may reveal alternative host response factors previously unrecognized in the current disease
model of influenza.
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Introduction
Disease progression remains poorly understood in influenza A
infection. Each year, millions of individuals worldwide are infected
with influenza virus [1]. It remains unknown as to why some
became critically ill whilst others infected with the same virus
remain relatively unaffected. Although vvirus related factors have
been proposed as influencing disease progression, data from recent
pandemic H1N1 2009 influenza shows that the similar viral loads
were found in the infected hosts regardless of disease severity [2,3].
Host response has also been suggested to play a role. However, its
exact contribution to disease progression has been for a long time
a matter of debate. While some studies show that an exaggerated
inflammatory response may be responsible [4,5], others have
shown that a delayed/reduced inflammatory response can also
contribute [6].
A better understanding of how host response determines the
progression of influenza infection is critically important for two
reasons. First, a greater insight into the mechanisms that modulate
host response may lead to the development of new therapeutic
agents. Second, clinical manifestation of influenza infection is
highly variable making it difficult to identify at-risk individuals.
Discovering new markers that indicate a decompensated host
response will assist clinicians in identifying individuals who are
more likely to progress to a more severe infection. Such a risk
stratification approach will allow clinicians to deliver prompt
treatment to at-risk individuals and hence reduce the fatality rate
from influenza-related complications.
Current understanding of influenza infection is limited by the
lack of an appropriate human model. Data supporting the
established model of influenza infection are predominantly from
in vitro and animal studies [7]. The pathophysiology of these
models, however, may profoundly differ from that in humans.
Here, we report the first human model that examines the role of
host response in influencing disease progression in influenza A
infection. Using gene-expression data derived from circulating
leukocytes in infected humans, we examined influenza induced
changes in signalling and metabolic maps covering the full
spectrum of known molecular pathways in human biology. We
show that dysregulated cell cycle activities in circulating leukocytes
characterise the progression to severe infection. We also
demonstrate that the loss of a coupling relationship between cell
cycle perturbation and apoptotic response in circulating leukocytes
marks the difference between a well contained, uncomplicated
viral illness and a rapidly progressing, severe infection. Put
together, these data implicate a major role of circulating leukocytes
in influencing disease outcomes in influenza infection.
Results
To identify the unique pathways that characterized progression
from mild to severe illness, we performed a meta-analysis of five
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between different categories of human influenza virus infection,
with each category representing a different stage of immune
activation (Fig. S1). These categories included (1) healthy subjects
after influenza vaccination (hereafter referred to as ‘‘Post-
Vaccination’’ group), (2) asymptomatic subjects with influenza A
H3N2 infection (hereafter referred to as ‘‘Asymptomatic’’ group),
(3) symptomatic subjects with influenza A H3N2 infection
(hereafter referred to as ‘‘Symptomatic’’ group) and (4) critically
ill subjects with influenza A H1N1 pneumonia (hereafter referred
to as ‘‘Severe’’ group). An additional group of critically ill subjects
with bacterial pneumonia was included as the positive control
(hereafter referred to as ‘‘Bacterial’’ group). The use of positive
control allowed us to distinguish between a generic host response
(found in most infection, whether it is viral or bacterial) and a
specific host response attributable due to influenza viral infection.
A total of 55 subjects were included in the analysis. The
demographic and clinical information of the included subjects
are given in table 1. Immunocompromised patients (e.g., history of
receiving corticosteroids therapy or immunosuppressive medica-
tions, transplant recipients, haematological malignancies) were
excluded from our study. Hierarchical clustering of global gene
expression using centred correlation and average linkage was
performed for each of the data sets and shows that samples within
each particular group tend to cluster together (Fig. S2).
We found that infection severity correlates with the extent of
systemic host response. An intense systemic response is seen in the
Severe and Symptomatic groups (Fig. 1). In contrast, a minimal
response is seen in the Asymptomatic group and none at all in the
Post-vaccination group. Activation of this host response correlates
with the expression of the virus detection genes TLR7 (Toll-like
receptor 7), RIG-1 and MDA-5. In the Severe and Symptomatic
groups, these genes are highly expressed whereas in the Post-
vaccination or Asymptomatic groups, there is minimal expression
of these genes (Fig. 2A, 2B, 2C). In the Symptomatic and Severe
groups, the activation signal is seen in both external and internal
viral recognition systems. TLR7, the receptor for detecting virus
antigens on the host cell surface, shows up to a five-fold increase in
gene-expression. RIG-1 and MDA-5, the intra-cellular alarm
system for detecting viral RNA, show up to a six-fold increase.
There is evidence of viral-induced apoptosis, which is consistent
with the increase in expression of TLR-7, RIG-1 and MDA-5. The
PKR-dependent apoptosis pathway, known to be involved in
influenza virus infection, is activated in both the Symptomatic and
Severe groups (Fig. S3A, S3B). There is also a concurrent
activation of the anti-viral pathway mediated by type I interferon
genes, with up to a ten-fold increase in some of these genes (Fig.
S4A). As infection resolves, the viral detection signal declines and
this is followed by the return of the interferon response to a
quiescent state (Fig. 2D, Fig. S4C).
We found that the systemic host response in severe infection
differs significantly from that of mild infection. The main
differences lay in the cell cycle and apoptosis pathways.
Unexpectedly, immune response pathways did not differ signifi-
cantly between infected groups. Other than TNF and IL-beta,
inflammation-related genes that are well established in influenza
infection do not discriminate between these groups (Fig. S4B).
Also, interferon response genes do not differ significantly between
mild and severe influenza infection (Fig. S4A). The lack of
correlation among established immune/inflammatory markers led
us to postulate that disease progression is determined by changes
occurring elsewhere, such as in the cell cycle and apoptosis
pathways.
Further analyses revealed that there is a significantly greater
number of cell cycle pathways activated in severe influenza
infection compared to mild infection (Fig. 3). In addition, the
Severe group shows a greater up-regulation of genes encoding for
key cell cycle proteins (Fig. 4). These cell cycle proteins include
cyclin and their associated catalytic kinase enzymes, namely, cyclin
E( G 1–S phase transition), cyclin A (S-phase progression), cyclin B
(G2–M phase transition), CDK1 and CDK2. Furthermore, this
up-regulation is accompanied by an extensive activation of DNA
replication machinery, including the pre-replication complex
assembly, MCM complex and Cdt1 (Fig. S5A, S5B). The
heightened DNA replication activity does not seem to be host
cell initiated because cyclin D, the initiator of cell cycle, is
paradoxically down-regulated. Importantly, the increased DNA
synthesis occurs in the context of an abnormally low leukocyte
response to infection (Fig. S5E), indicating that it is not a
physiologically normal response.
Despite an increase in DNA synthesis, paradoxical changes
were seen in the mitotic phase. Here, we found up-regulation of
genes opposing the completion of mitosis (Fig. 4), including those
encoding Securins (inhibitor of chromosomes separation) and the
Condensin Complex (structural maintenance of chromosomes).
Furthermore, there is strong activation of the spindle checkpoint
complex (MD2a, MD2b and BUBR1), the cellular sensing system
that normally prevents premature separation of chromosomes.
Together, these proteins maintain chromosome condensation and
their up-regulation is known to be associated with delayed mitotic
exit [8]. To understand the mechanism underlying this finding, we
focused on the anaphase promoting complex (APC), the major
regulatory complex that coordinates cell cycle progression and exit
from mitosis [9], which was also the most statistically significant
pathway found in our analysis (Fig. 3). Here we found abnormal
changes in APC and its two co-activators (CDC20 and hCDH1).
Table 1. Patient characteristics in the included studies.
No. of
Subjects
Age
Mean (range)
Gender
Female/Male
APACHE
II score - mean
(range)
Site of
infection
Survival/
Death
Length of
follow-up
Severe influenza infection 4 33 (21–48) 3/1 14 (13,17) Lung 4/0 5 days
Severe bacterial pneumonia 6 63 (52–75) 3/3 22 (10,33) Lung 4/2 5 days
Mild influenza infection 9 NA NA NA Lung 9/0 3.5 days
Post-vaccination subjects 18 43 (24–70) 12/6 NA NA 18/0 7 days
Healthy controls 18 43 (24–70) 12/6 NA NA 18/0 1 day
APACHE denotes Acute Physiology and Chronic Health Evaluation II scores. NA denotes not available or not applicable.
doi:10.1371/journal.pone.0017186.t001
Decompensated Host Response to Severe Influenza
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upregulated whilst no activation is seen in hCDH1 (Fig. S5C).
Most importantly, the APC gene is not expressed at all. In
summary, severe influenza infection is characterized by opposing
changes in cell cycle activity (accelerating DNA synthesis but
delayed mitotic exit) and these changes are associated with
dysregulated cell cycle control.
In contrast to changes in cell cycle, the apoptosis pathways were
activated to a greater degree in mild infection than in severe
infection (Fig. 5A). Given that cell cycle perturbations are known
to trigger apoptosis [10], we proceeded to investigate if host cell
related mechanisms (via cell cycle genes) may be implicated in
causing this difference. Nibrin, GADD45 and PCNA, which are
cell cycle genes involved in detecting genetic damage and
promoting DNA repair, are highly expressed in both the Severe
and Symptomatic groups (Fig. S5D). Importantly, the genes which
link DNA-damage response to apoptosis are also up-regulated. We
therefore used network analysis to further explore the relationship
between cell cycle and apoptosis genes. We first built networks (by
direct interaction) using apoptosis and cell cycle genes separately.
Within the cell cycle network, connectivity for DNA-damage
response genes was further expanded. Cell cycle and apoptosis
networks were then merged so that we could identify any
reciprocal relationship between these networks. This analysis
revealed that, in mild infection, the cell cycle network is highly
integrated with an efficient programmed cell death response
(Fig. 5B). The integration is mediated predominantly via a p53-
dependent DNA-damage response pathway. In contrast, such
integration is lost in severe infection. Here, the DNA-damage
response signals are not only considerably weaker, but they also
fail to couple with the apoptosis network (Fig. 5C). This may
reflect the host’s attempt, albeit unsuccessful, to limit genome
damage and restore homeostasis during influenza infection. Since
apoptosis allows the host to eliminate non-viable cells and limit
virus replication, the loss of this self-preservation response,
combined with cell cycle perturbations, may mark the difference
between mild and severe infection.
The above observations also reveal important differences
between severe and mild infection. In severe infection, host
circulating leukocytes undergo extensive transcriptional repro-
gramming (increased G1/S phase activity, delayed G2/M phase
progression and de-coupling of the cell cycle-apoptosis relation-
ship). In contrast, mild infection shows considerably fewer changes
and asymptomatic infection shows no changes at all. These
differences may reflect shifting changes in immune cell populations
during different stages of the influenza infection. For example, in
the early stage of influenza infection, CD4
+ cells differentiate into
T-helper 1 cells (Th1) and a bias towards Th1 cells development
protects host from severe infection [11]. We therefore examined
the cellular origins of the gene-expression signals detected in both
severe and mild influenza infection, in order to see if the changes
in immune cell populations mirror the difference in transcriptional
profiles between these two groups (Fig. 6). Using cell tagging via
the ImmGene, we found that gene-expression signals related to
Figure 1. Top significant biological processes during host response to influenza. P-value distribution of the most significant biological
processes during host response to influenza infection in Severe, Symptomatic and Asymptomatic groups; Post-Vaccination group is not shown as no
significant pathway is represented in this group. Bacterial group is included as a control.
doi:10.1371/journal.pone.0017186.g001
Decompensated Host Response to Severe Influenza
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group compared to the mild influenza group (p=0.00026). On the
other hand, Th1 cells are more represented in the mild influenza
group (p=0.072). This finding confirms that the observed
differences in transcriptional activities do parallel a shift in
immune cell sub-populations between mild and severe infection.
However, the precise relationship between transcriptional repro-
gramming and specific immune cells sub-populations remains
unknown and this warrants further study.
Discussion
A prevailing view in the established model of influenza infection
is that dysregulated inflammatory response in the lungs drives the
progression towards a more severe disease [4,5,6,12]. However,
the evidence for this mechanism is based almost exclusively on
animal studies [7]. Emerging human data from studies of the
recent H1N1 virus pandemic revealed that host factors beyond
that of lung parenchyma are also likely to contribute to disease
progression [2]. We therefore developed a human model of
influenza A infection to delineate these systemic host factors and to
understand their role in driving disease progression in infected
individuals. Using a human model incorporating varying infection
severity, we found important differences in pathway profiles of
circulating leukocytes between asymptomatic, mild and severe
influenza infection. The severe influenza infection group shows the
most profound changes by having the greatest number of cell cycle
pathways perturbed. These changes are characterized by an
increased aberrant DNA replication in the G1/S phase but a
delayed exit from the G2/M phase. The increased DNA
replication is associated with an impaired leukocyte response to
infection, suggesting that the delayed mitotic exit may be the key
step that limits leukocyte proliferation during influenza infection.
Given that circulating immune cells constitute the main effector
arm of the cell mediated response against influenza viral infection,
our findings suggest that these cells may play a major role in
determining the outcome of influenza infection.
Our findings on cell cycle perturbations are consistent with
emerging experimental data. Aberrant DNA replication activity
has recently been shown to occur during influenza virus infection
[13]. The MCM complex, a helicase involved in eukaryotic DNA
replication, has been identified as the host factor used by influenza
A virus to increase viral replication [13]. Delayed mitotic exit has
also been implicated in the pathogenesis of viral infection and it is
Figure 2. Expression levels of viral detection genes. Expression levels of viral detection genes (A) TLR-7, (B) RIG-1 and (C) MDA-5 in all groups.
(D) Expression level of viral detection genes TLR-7, RIG-1 and MDA-5 as infection resolves. Base-line expression level is represented as fold-change of1 .
doi:10.1371/journal.pone.0017186.g002
Decompensated Host Response to Severe Influenza
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doi:10.1371/journal.pone.0017186.g003
Figure 4. Cell cycle genes in severe influenza infection. Only statistically significant genes are shown. Cell cycle phases are represented as G1,
S, G2 and M. Up-regulated genes are coloured red and enclosed in ovals. Cyclin A, B and E are also up-regulated.
doi:10.1371/journal.pone.0017186.g004
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study, both up-regulation of the MCM complex and dysregulation
of the APC are evident in the most severely infected patients.
Our findings also reveal a critical role of apoptosis in influenza
infection. While apoptosis has been widely reported in studies of
influenza infection, its implication on disease progression has not
been well understood. Conflicting evidence exist as to whether
apoptosis is harmful or beneficial to the host during influenza
infection [14]. Our findings demonstrate that, rather than
apoptosis per se, it is the coupling relationship between cell cycle
perturbations and apoptosis that may influence the outcome of the
disease. Furthermore, our data suggests that this coupling
relationship is mediated via the p53-dependent pathway, a well
established self-repair pathway that limits DNA damage and cell
cycle perturbations in host cells. Recent evidence supports this
finding. In influenza virus infected human lung cells, p53 is shown
to be essential for the induction of apoptosis and its inhibition
resulted in elevated virus replication [15]. In mice infected with
the influenza virus, an increased activation of the p53 dependent
DNA-damage response (G2/M checkpoint) is associated with
reduced lung inflammation and better survival [5].
Put together, our findings reveal a systematic loss of control by
the host leukocytes over key cellular functions, including DNA
synthesis, mitotic exit and self-repair response. As infection
resolved, these perturbations subsided and were accompanied by
a recovery in host response including lymphocyte, monocyte and
neutrophil cell counts (Fig. 7a, 7b). Leukocyte proliferation is an
important of part of the host immune response and is critical for
the clearance of influenza infection [16]. Cell cycle perturbations
may impair leukocyte proliferation, leading to a significantly
diminished host response and consequently a more severe
infection. Our results therefore suggest a plausible mechanism
for explaining why some individuals succumb to severe influenza
infection whilst others recover quickly after having only a relatively
mild illness.
Previous studies have focused predominantly on the role of
immune cells in lung parenchyma and local lymphoid tissue in
driving disease progression. It is commonly believed that disease
progression occurs when influenza virus replication overwhelms
the local defence mediated by immune cells in the lung. However,
such a model fails to explain why viral loads assayed from airway
samples in infected human are similar regardless of disease
severity, a finding consistently observed in the recent pandemic
H1N1 influenza infection [3,17,18]. This study provides an
alternative mechanism to explain disease progression during
influenza infection. Our findings suggest that, during primary
Figure 5. Relationship between apoptosis and cell cycle. (A) Apoptosis and cell cycle pathways during influenza infection. Direct interaction
networks for cell cycle and apoptosis genes in (B) mild influenza A infection and (C) severe influenza A infection. Dark blue lines represent apoptosis
whereas green lines represent cell cycle pathways. The pale blue line indicates that these genes are involved in both apoptosis and cell cycle
pathways. The thin edges represent the expanded network of the DNA-damage response pathway. Coloured circles above individual genes indicate
up (red) or down (blue) regulation.
doi:10.1371/journal.pone.0017186.g005
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PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17186influenza infection, an unabated cell cycle dysregulation in
systemic immune cells diminishes host response. Host cells respond
by programmed cell death to eliminate non-viable cells and to
limit genome damage. The manner by which the influenza virus
modulates this response may very well represent the distinguishing
features between a mild, self-limiting illness and a highly lethal
infection.
There are limitations in our study. First, different influenza virus
strains were used in the study. Ideally, each group being infected
with the same virus will allow a more valid comparison between the
groups. Second, an inherent limitation with observational study is
that groups differ not just in the phenotype of interest (severe
infection vs. mild infection), but also in other characteristics as well
(e.g. age, gender, co-existing medical conditions). These other
characteristics could have confounded our findings. Third, two
different microarray platforms were used in generating data for this
study. The difference in technology may have introduced artifectual
differences that may potentially dilute the real biological signals.
In conclusion, our study extends the established influenza model to
include a key role for circulating leukocyte response to infection. The
discovery of a significant pathology in circulating leukocytes provides
an additional perspective from which to interrogate the role of host
response in influenza infection. It also provides an opportunity to
develop new diagnostic and therapeutic approaches. Importantly, the
discovery of infection progression signature markers may help address
the prevailing challenge in an influenza pandemic, namely, to
distinguish high risk individuals from a vast number of uncomplicated,
self-limited infected cases. An improved ability to stratify, select and
protect high risk individuals has major public health implications, as
we anticipate the arrival of the next influenza pandemic.
Materials and Methods
Subjects
Critically ill patients with severe infection were enrolled in our
study. Severe infection is defined asinfection where there is at least one
major organ failure (e.g. respiratory failure) that requires critical care
intervention (e.g. mechanical ventilation). Viral infection (n=4) was
confirmed using PCR and bacterial infection (n=6) by microbiolog-
ical cultures. Healthy volunteers (n=18) were enrolled from a local
influenza vaccination program. Whole blood samples were drawn
from all subjects. For critically ill patients, sampling coincided with
their peak clinical symptoms. These critically ill patients were followed
up for a further four days to assess their recovery profiles. A previously
published report provide the gene-expression data of 17 subjects with
mild seasonal influenza infection [19]. In symptomatic subjects (n=9),
gene-expression data on the day of peak symptoms was analysed. In
asymptomatic subjects (n=8), gene-expression data obtained after an
average of 3.5 days was analysed.
Viruses
Subjects from the Symptomatic and Asymptomatic groups were
infected with the seasonal H3N2 influenza virus. Subjects from the
critically ill viral infection group were infected with the pandemic
H1N109 influenza virus.
Expression analysis
Samples were collected into PAXgene tubes. Upon collection,
the samples were immediately stored at minus 20 degrees Celsius.
RNA extraction was performed in batches of 12–24 samples at a
time. Samples were first incubated at room temperature for
Figure 6. Cell tagging via ImmGen – Symptomatic and Severe influenza infection. Representation of (A) 6 immune cell subsets and (B)T
cell subsets in the top 100 up-regulated genes of the Symptomatic and Severe influenza infection groups.
doi:10.1371/journal.pone.0017186.g006
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the PAXgene RNA extraction kit (PAXgene
TM Blood RNA kit -
Qiagen, Germany). Extracted RNA was then stored at minus 80
degrees Celsius until required for amplification and labelling using
Illumina TotalPrep Amplification kit. Prior to sample amplifica-
tion and labelling, RNA quality was analysed using Agilent
Bioanalyser and all samples obtained a RIN of greater than 6.5.
Amplification and labelling was carried out 24 samples at a time.
200ng of Total RNA was used as the starting quantity for
amplification and labelling of all samples. Once the amplification
and labelling was completed, the amplified cRNA was also
assessed using the Agilent Bioanalyser, to ensure satisfactory
amplification. The samples were then immediately hybridised on
the HT-12 beadchips. 750ng of each sample was loaded on to the
arrays. The hybridisation and washing procedure was identical for
each set of arrays processed and after normalisation, no significant
batch effects were identified.
All of the RNA extraction, sample amplification and labelling,
hybridisation and washing, and scanning procedures were carried
out by the same operator, at the same time of day. Sample signals
were normalized with cubic spline and then log-transformed prior
to analysis. All microarray data are available at GEO (GSE20346),
in accordance with minimum information about a microarray
experiment (MIAME) standards.
Bioinformatic workflow
Five data sets were analysed (Fig. S1). Analysis of each data set
began with the identification of a signature gene list from each
data set. This is done by comparing the diseased patients (e.g. mild
influenza infection) to a group of control subjects (healthy
volunteers). This generates a list of differentially expressed genes
that represents an unique signature for that disease status.
Differential expression analysis was performed in each data set
using BRB-ArrayTools. In groups with a longitudinal study design,
differentially expressed genes were identified using the ANOVA
mixed effects model, with disease and time as fixed effects factors
and subject as random factor. In groups with a before-and-after
study design, differentially expressed genes were identified using
the paired t-test (Fig. S1).
When generating differentially expressed genes, the diseased
group was compared to the healthy controls within the same
cohort. Hence each patient group was compared to its own control
group on the same microarray platform (e.g. Affymetrix), ensuring
that the comparison between groups was not confounded by the
difference in technology (e.g. Affymetrix vs. Illumina).
To undertake pathway analysis, the generated differentially
expressed genes were uploaded into the GeneGO
TM MetaCore
TM
(St. Joseph, MI, USA). MetaCore is an integrated software suite
for functional analysis of gene-expression data. The software is
based on an extensively curated database of protein structures and
molecular interactions, and is substantially more comprehensive
than the knowledge base provided by KEGG and Biocarta. Using
MetaCore, pathway analysis and network analysis were performed
in each data set. Pathway analysis involves matching a list of pre-
specified genes onto canonical pathways and calculating the
statistical relevance of the matches found. Each canonical pathway
represents the current consensus knowledge of a specific biological
process including intracellular cell signalling, regulatory processes
and metabolic processes. Results are presented as pathway maps
with overlaying gene-expression data. A false discovery rate of 5%
is used as the cut-off to determine if a pathway is statistically
significant. Network analysis was performed within GeneGo using
pre-specified genes as root objects and then subsequently
expanded based on known biological relationships and protein/
gene interactions.
Cell tagging
To identify the cellular sources of the gene-expression signals,
we performed cell tagging analysis using ImmGen. ImmGen is a
public data gene-expression repository consisting of whole-genome
microarray datasets for nearly all characterized cell populations of
the adaptive and innate immune systems [20]. Using the query
function in the ImmGen, all the immune cell subtypes that express
a particular gene can be identified (cell tagging) [21]. This
approach allows identification of the multiple cell types that
express the same gene, as well as knowing whether the gene is
expressed in either the activated state or the resting state of the
cell. To identify the immune cell sub-populations that give rise to
the most significant genes, the top 100 highest-ranking up-
regulated genes from the Symptomatic H3N2 and Severe H1N1
groups were used. Each gene was then searched in ImmGen using
the immunological genome browser for human immune cells (e.g.
monocytes, dendritic cells, Th1 and Th2). The cell types that
express the top 100 significant genes were then collated for both
the Symptomatic and the Severe groups. Fisher’s exact test is then
used to determine whether the representation of any particular
immune cell type is statistically different between the two groups.
PCR
We performed qPCR on selected cell cycle and apoptosis genes.
The findings from qPCR show that the gene-expression level
correlates well with those from microarray experiments. These
findings are presented in Table S1.
Data Deposition
All microarray data has been deposited in GEO (record number
- GSE20346).
Supporting Information
Figure S1 Schematic representation of study design and
bioinformatic workflow.
(TIF)
Figure S2 Hierarchical clustering of global gene expres-
sion using average linkage and centred correlation. (A)
Heatmap of data sets assayed on the Illumina Platform. (B)
Heatmap of data sets assayed on the Affymetrix platform.
(TIF)
Figure S3 PKR-dependent apoptosis in mild (A) and
severe (B) influenza A infection. Pale blue lines indicate
direct interaction with PKR. Coloured circles above individual
genes indicate up (red) or down (blue) regulation.
(TIF)
Figure S4 Interferon and Inflammatory response in
mild and severe influenza A infection. (a) Expression level of
interferon related genes in mild and severe influenza A infection.
Figure 7. Recovery from severe influenza A Infection. (A) Attenuation of apoptosis and cell cycle expression levels during recovery. Control
refers to healthy volunteers. (B) Recovery of total leukocytes, lymphocytes, monocytes and neutrophils as infection resolves in the Severe group.
Immune cell counts were collected as part of the routine clinical tests performed in the ICU.
doi:10.1371/journal.pone.0017186.g007
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PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e17186Day 1 samples are shown for the severe group. (b) Expression level
of inflammatory cytokine genes. Day 1 samples are shown for the
severe group. (c) Heatmap of interferon related genes during
recovery in severe influenza A infection.
(TIF)
Figure S5 DNA replication and Cell cycle pathways and
leukocyte response in severe influenza A infection. (a)
Pathway diagram for start of DNA replication in early S
phase. Red bars indicate up-regulation and blue bars indicate
down-regulation. Bars labelled 1 refer to severe influenza A
infection and bars labelled 2 refer to mild influenza A infection. A
detailed description of this map can be found at http://www.
genego.com/map_705.php. (b) Pathway diagram for tran-
sition and termination of DNA replication. Red bars
indicate up-regulation and blue bars indicate down-regulation.
Bars labelled 1 refer to severe influenza A infection and bars
labelled 2 refer to mild influenza A infection. A detailed
description of this map can be found at http://www.genego.
com/map_707.php. (c) Pathway diagram for the role of
APC in cell cycle regulation. Red bars indicate up-regulation
and blue bars indicate down-regulation. Bars labelled 1 refer to
severe influenza A infection and bars labelled 2 refer to mild
influenza A infection. A detailed description of this map can be
found at http://www.genego.com/map_472.php. (d) Pathway
diagram for role of ATM/ATR regulation of G1/S
checkpoint in DNA damage. Red bars indicate up-regulation
and blue bars indicate down-regulation. Bars labelled 1 refer to
severe influenza A infection and bars labelled 2 refer to mild
influenza A infection. A detailed description of this map can be
found at http://www.genego.com/map_426.php. (e) Leukocyte
response to severe infection. Leukocyte response on day 1 in
subjects with severe viral pneumonia and bacterial pneumonia.
Data is based on subjects from Severe group (n=4), Bacterial
group (n=6) and healthy volunteers (n=18).
(TIF)
Table S1 Validation of representative genes by poly-
merase chain reaction (PCR).
(DOC)
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